Navigation Links
Redsense Medical Receives FDA Clearance for the Redsense Safety Device for Home/Self use During Home Hemodialysis
Date:5/18/2010

HALMSTAD, Sweden, May 18, 2010 /PRNewswire/ --

- With Photo

The Redsense safety device is now cleared by FDA for Home/Self use and is consequently available to all patients with home hemodialysis in the US. Redsense safety device is designed to detect venous needle dislodgement during hemodialysis and its use has already improved in-clinic patient safety. Optimizing safety conditions for home hemodialysis users is a core ambition for Redsense Medical.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100518/391613 )

Dialysis equipment today is required to have a system which protects the patient from blood loss due to dislodgement of the venous needle. The commonly accepted solution is to monitor by the venous pressure alarm but a better solution has long been requested. Even with the routine supervision of medical staff still the venous needle can become dislodged: the dialysis machine will then continue to draw blood from the patient's artery however not returning blood in the loop circuit as the venous needle has become dislodged and the patient's blood ends up elsewhere. If undetected, this blood loss can have very serious consequences in only a few minutes. Redsense safety device provides a solution to this problem and detects venous needle dislodgement instantaneously; it only takes a few millilitres of blood on the sensor patch to sound the alarm.

It is well known that home hemodialysis allows for daily treatments, improving quality of life, morbidity and life expectancy. Home hemodialysis is also more cost-effective as it can free hospital beds and reduces the transport costs related to centralized dialysis care.

Being able to address the market for home hemodialysis is an important step according to, CEO Patrik Byhmer:

    - This is where Redsense really can make a difference. It's very
      satisfying being able to increase the level of safety among the users
      of home hemodialysis.

The company

Redsense Medical has offices in Sweden and in the U.S. (Chicago, IL). For more information: http://www.redsensemedical.com.

The product

The Redsense safety device is the results of close co-operation between medical staff and engineers. Redsense consists of two parts: a sensor patch and an alarm unit. An infrared signal is transmitted from the alarm unit to the sensor patch using fibre optic cable. In the event of bleeding, inner layers of the patch smear blood over the optical sensor, which triggers the alarm.


'/>"/>
SOURCE Redsense Medical AB
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ultra-Fine Metal Tubing Smoothes the Way for Miniaturized Medical Devices
2. Elekta / Mitsubishi Electric Collaboration Helps Japans Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer
3. TriReme Medical, Inc. Receives FDA 510(k) Clearance for a Broad Matrix of GliderXtreme(TM) PTA Balloon Catheter Sizes
4. China Sky One Medical Provides Sales Forecast for 13 New Products
5. China Sky One Medical Attended Import and Export Fair to Enhance International Growth Opportunity
6. Winner Medical Reports Second Quarter Results for the Fiscal Year 2010
7. China Sky One Medical Announces Preliminary First Quarter 2010 Results; Reschedules Earnings Conference Call
8. China Sky One Medical Announces Conference Call to Discuss First Quarter 2010 Results
9. PolyTouch Medical Ltd. Announces the Submission of a Premarket Application for PatchAssist - an Innovative Mesh Deployment and Placement Device for Laparoscopic Hernia Repair
10. BioMS Medical updates University of Alberta equity position
11. InterTech Service to Counter Widely Reported Problems in Automotive, Medical Device and Other Industries Requiring Rigorous Quality Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...   Ginkgo Bioworks , a leading organism ... today awarded as one of the World Economic ... most innovative companies. Ginkgo Bioworks is engineering biology ... world in the nutrition, health and consumer goods ... customers including Fortune 500 companies to design microbes ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
Breaking Biology Technology:
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
Breaking Biology News(10 mins):